Corcept Therapeutics (CORT) PT Raised to $29 at Truist Securities
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $110.51 -1.49%
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
7 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Truist Securities analyst Joon Lee raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $29.00 (from $26.00) while maintaining a Hold rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Adyen NV (ADYEN:NA) (ADYYF) PT Raised to EUR1,278 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
